UPDATE 1-AI drug hunter BenevolentAI worth $2 bln after fund raising
April 19, 2018 at 03:17 AM EDT
LONDON, April 19 (Reuters) - BenevolentAI, a British drug developer that uses artificial intelligence to identify new medicine candidates, said it had raised $115 million in a funding round that valued it at $2 billion.
